CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop new antibiotics to combat drug-resistant bacteria using nanomaterials. It focuses on understanding the toxicological effects of these materials on individual bacteria to create effective drug delivery systems.
Bacterial resistance to antibiotics is one of medicine's most vexing challenges.
Most antibiotics initially work really well, killing more than 99.9% of microbes they target.
But through mutation and the selection pressure exerted by the antibiotic, a few inevitably manage to survive, and flourish as antibiotic-resistant strains.
Hence, new strategies to design antibiotic to combat drug-resistant bacteria are required.
Many drug delivery systems based on nanomaterials have been developed during…
FUNDACION IMDEA NANOCIENCIA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
